Graduate School of Health Management, Keio University, Tokyo, Japan
Graduate School of medicine, Kobe University, Kobe, Japan.
BMJ Open. 2024 Apr 5;14(4):e072688. doi: 10.1136/bmjopen-2023-072688.
Nationwide lifestyle intervention-specific health guidance (SHG) in Japan-employs counselling and education to change unhealthy behaviours that contribute to metabolic syndrome, especially obesity or abdominal obesity. We aimed to perform a model-based economic evaluation of SHG in a low participation rate setting.
A hypothetical population, comprised 50 000 Japanese aged 40 years who met the criteria of the SHG, used a microsimulation using the Markov model to evaluate SHG's cost-effectiveness compared with non-SHG. This hypothetical population was simulated over a 35-year time horizon.
SHG is conducted annually by all Japanese insurers.
Model parameters, such as costs and health outcomes (including quality-adjusted life-years, QALYs), were based on existing literature. Incremental cost-effectiveness ratios were estimated from the healthcare payer's perspective. Deterministic and probabilistic sensitivity analyses (PSA) were conducted to evaluate the uncertainty around the model input parameters.
The simulation revealed that the total costs per person in the SHG group decreased by JPY53 014 (US$480) compared with that in the non-SHG group, and the QALYs increased by 0.044, wherein SHG was considered the dominant strategy despite the low participation rates. PSA indicated that the credibility intervals (2.5th-97.5th percentile) of the incremental costs and the incremental QALYs with the SHG group compared with the non-SHG group were -JPY687 376 to JPY85 197 (-US$6226 to US$772) and -0.009 to 0.350 QALYs, respectively. Each scenario analysis indicated that programmes for improving both blood pressure and blood glucose levels among other risk factors for metabolic syndrome are essential for improving cost-effectiveness.
This study suggests that even small effects of counselling and education on behavioural modification may lead to the prevention of acute life-threatening events and chronic diseases, in addition to the reduction of medication resulting from metabolic syndrome, which results in cost savings.
日本全国范围内的生活方式干预专项健康指导(SHG)采用咨询和教育来改变导致代谢综合征的不健康行为,尤其是肥胖或腹部肥胖。我们旨在针对低参与率环境下的 SHG 进行基于模型的经济评估。
一个由 50000 名符合 SHG 标准的 40 岁日本成年人组成的假设人群,使用马尔可夫模型的微观模拟来评估 SHG 与非 SHG 相比的成本效益。这个假设人群在 35 年的时间跨度内进行模拟。
SHG 由所有日本保险公司每年进行。
模型参数,如成本和健康结果(包括质量调整生命年,QALYs),基于现有文献。从医疗保健支付者的角度估计增量成本效益比。进行确定性和概率敏感性分析(PSA)以评估模型输入参数的不确定性。
尽管参与率较低,但模拟结果显示,SHG 组的人均总成本比非 SHG 组减少了 53014 日元(480 美元),QALYs 增加了 0.044。尽管如此,SHG 仍然被认为是一种主导策略。PSA 表明,与非 SHG 组相比,SHG 组的增量成本和增量 QALYs 的可信度区间(2.5 百分位至 97.5 百分位)分别为 -6226 至 -85197 日元(-772 美元至 -687376 美元)和 -0.009 至 0.350 QALYs。每个情景分析表明,改善代谢综合征其他危险因素(如血压和血糖水平)的方案对于提高成本效益至关重要。
本研究表明,即使咨询和教育对行为改变的影响很小,也可能会预防急性危及生命的事件和慢性疾病,同时减少代谢综合征导致的药物治疗,从而节省成本。